Advertisement

Topics

NSTI Company Profile

19:42 EST 17th November 2017 | BioPortfolio

The Nano Science and Technology Institute (NSTI; www.nsti.org) advances and integrates nano and other advanced technologies through education, conventions, business publishing, and research services. NSTI produces the annual TechConnect World (Nano, Micro, BioNano and Clean Technologies) Conferences and Expo, which attracts more than 5,000 industrial, academic, business and governmental attendees from around the word. It is the world's largest gathering of emerging technology providers, investors and corporate developers all focused specifically on the commercialization of advanced technologies. NSTI was founded in 1997 as a result of the merger between various scientific societies, and is headquartered in Cambridge, Massachusetts with offices in California and Switzerland.


News Articles [1 Associated News Articles listed on BioPortfolio]

Atox Bio Awarded Next Milestone-based Option by BARDA to Support Continued Development of Reltecimod for Necrotizing Soft Tissue Infections

NESS ZIONA, Israel and CHAPEL HILL, North Carolina, Sept. 25, 2017 /PRNewswire/ -- Atox Bio today announced that it has been awarded the next option on a performance-based contract with the Biomedical...

Drugs and Medications [0 Results]

None

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Associations of Plasma Nitrite, L-Arginine and Asymmetric Dimethylarginine with Morbidity and Mortality in Patients with Necrotizing Soft Tissue Infections.

The nitric oxide system could play an important role in the pathophysiology related to necrotizing soft tissue infection (NSTI). Accordingly, we investigated the association between plasma nitrite lev...

Management and Novel Adjuncts of Necrotizing Soft Tissue Infections.

Necrotizing soft tissue infections (NSTI) have been recognized for millennia and continue to impose considerable burden on both patient and society in terms of morbidity, death, and the allocation of ...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Prognosis and Treatment of Necrotizing Soft Tissue Infections: A Prospective Cohort Study

The investigators will analyze biomarkers related to the prognosis and treatment of necrotizing soft tissue infections (NSTI). The focus will be on whether certain endothelial and immune s...

Companies [2 Associated Companies listed on BioPortfolio]

NSTI, LLC

The Nano Science and Technology Institute (NSTI; www.nsti.org) advances and integrates nano and other advanced technologies through education, conventions, business publishing, and research services. ...

NSTI

The Nano Science and Technology Institute (NSTI; www.nsti.org) advances and integrates nano and other advanced technologies through education, conventions, business publishing, and research services. ...

More Information about "NSTI" on BioPortfolio

We have published hundreds of NSTI news stories on BioPortfolio along with dozens of NSTI Clinical Trials and PubMed Articles about NSTI for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NSTI Companies in our database. You can also find out about relevant NSTI Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record